Investor insights
Sectors invested in
Medical1
Life Science1
Biotechnology1
Funding rounds participated in
$12M sweet spot round size
Most of their 1 investments are in rounds between $12M and $12M
Investor type
Family Investment Office
Basic info
Industry
financial services
Sectors
Growth Capital
Private Equity
Long-term Capital
Distressed Situations
Date founded
2019
Investments made
T
ThromboGenics NV raised $12M on March 3, 2022
Investors: Epacria Capital Partners